🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is being conducted to identify how much and how often pralatrexa...
Status
Completed
Location
City of Hope National Medical Center
Start Date
2007-08
Trial ID
NCT00554827
Treatments Being Tested
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
This study is to evaluate the objective response rate to pralatrexate in As...
Status
Unknown
Location
Ntional Taiwan University Hospital
Start Date
2016-08-30
Trial ID
NCT03150602
Treatments Being Tested
This study is to evaluate the effect of leucovorin in preventing or reducin...
Status
Completed
Location
City of Hope
Start Date
2014-07
Trial ID
NCT02106650
Treatments Being Tested
A Phase 3, randomized, 2-arm, open-label, multicenter, stratified study of ...
Status
Recruiting
Location
City of Hope National Medical Center
Start Date
2024-10-02
Trial ID
NCT06561048
Treatments Being Tested
This is a study to test how safe the combination of the drugs Romidepsin an...
Status
Completed
Location
Beth Israel Deaconess Medical Center
Start Date
2013-09-09
Trial ID
NCT01947140
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-05
Trial ID
NCT00024245
Treatments Being Tested
The purpose of this study is to determine whether pralatrexate, given with ...
Status
Completed
Location
The University of Arizona Health Sciences Center
Start Date
2008-07
Trial ID
NCT00722553
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2002-08
Trial ID
NCT00052442
Treatments Being Tested
This is a multicenter, prospective study of Pralatrexate combined with Chid...
Status
Not Yet Recruiting
Location
Peking University, Institute of Hematolgoy, Beijing,
Start Date
2024-12
Trial ID
NCT06671717